Obstetrics/Gynecology
RSSArticles
-
Did You Remember to Take Your Ginkgo?
-
Brief Update: Meningitis and Cochlear Implants
-
Highlights from the 8th Annual International Alzheimer’s Disease Meeting
-
Full September 29, 2002, Issue in PDF
-
A New Use for an Old Drug
-
How do Different Insulino-tropic Drugs Differ in their Effects on Fasting and Postprandial Insulin Secretion?
-
Pharmacology Update: Risedronate (Actonel) — A New Weekly Option for Osteoporosis
-
Clinical Briefs: MRC/BHF Heart Protection Study; Prolonged Erections and Dihydrocodeine/Sildenafil; Magnesium Supplementation of Blood Pressure
-
Family planning facilities meet the challenge of Lunelle syringe recall
If a large segment of your patient population is using the monthly contraceptive injection Lunelle, chances are that the last few weeks have been filled with contacting patients, answering questions, and counseling on backup contraception after the manufacturer issued a voluntary recall of prefilled syringes of the product. -
Bone loss in DMPA users mostly reversible
Add just-published research to your counseling on Depo-Provera (depot medroxyprogesterone acetate or DMPA): Use of the injectable contraceptive is strongly associated with bone density loss; however bone loss appears to be largely reversible once the injections are stopped.1